Related Experiment Video
Updated: Jun 24, 2026

X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models
Published on: December 9, 2022
Betulinic Acid for cancer treatment and prevention
1University Children's Hospital, Eythstr. 24, 89075 Ulm, Germany.
Abstract:
Betulinic acid is a natural product with a range of biological effects, for example potent antitumor activity. This anticancer property is linked to its ability to induce apoptotic cell death in cancer cells by triggering the mitochondrial pathway of apoptosis. In contrast to the cytotoxicity of betulinic acid against a variety of cancer types, normal cells and tissue are relatively resistant to betulinic acid, pointing to a therapeutic window. Compounds that exert a direct action on mitochondria present promising experimental cancer therapeutics, since they may trigger cell death under circumstances in which standard chemotherapeutics fail. Thus, mitochondrion-targeted agents such as betulinic acid hold great promise as a novel therapeutic strategy in the treatment of human cancers.
Insights
Betulinic acid, a natural compound, shows potent anticancer activity by inducing apoptosis in cancer cells via the mitochondrial pathway. Its targeted action on mitochondria offers a promising therapeutic strategy for human cancers.
Area of Science:
- Natural Products Chemistry
- Mitochondrial Biology
- Cancer Therapeutics
Background:
- Betulinic acid is a natural product with demonstrated antitumor effects.
- Its anticancer properties are associated with the induction of apoptosis through the mitochondrial pathway.
- Normal cells exhibit relative resistance, suggesting a therapeutic window.
Purpose of the Study:
- To investigate the potential of betulinic acid as a mitochondrion-targeted cancer therapeutic.
- To highlight its mechanism of action in inducing cancer cell death.
Main Methods:
- The study focuses on the biological effects and mechanism of action of betulinic acid.
- Analysis of its cytotoxicity against various cancer types and normal cells.
- Investigation of its interaction with the mitochondrial pathway of apoptosis.
Main Results:
- Betulinic acid exhibits potent antitumor activity.
- It effectively induces apoptotic cell death in cancer cells.
- Normal cells show relative resistance, indicating a therapeutic window.
Conclusions:
- Betulinic acid's targeted action on mitochondria makes it a promising agent for cancer therapy.
- It represents a novel therapeutic strategy, particularly when standard chemotherapeutics are less effective.
- Mitochondrion-targeted agents are valuable in experimental cancer therapeutics.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)